Prot# EN3348-303: A Phase 3, Randomized, Active-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of EN3348(MCC) as Compared with Mitomycin C in the Intravesical Treatment of Subjects wit BCG Recurrent or Refractory Non-Muscle

Project: Research project

Project Details

Effective start/end date2/2/122/2/15


  • Clinical Financial Services, LLC (EN3348-303 // EN3348-303)
  • Endo Pharmaceuticals Inc. (EN3348-303 // EN3348-303)